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Abstract
Background: Poor growth in early childhood has been considered irreversible after 2–3 years of age and has been
associated with morbidity and mortality over the short-term and with poor economic and cognitive outcomes over
the long-term. The MAL-ED cohort study was performed in eight low-income settings with the goal of evaluating
relationships between the child’s environment and experience (dietary, illness, and pathogen exposure, among
others) and their growth and development. The goal of this analysis is to determine whether there are differences
in the factors associated with growth from 24 to 60 months using two different metrics.
Methods: Across six MAL-ED sites, 942 children had anthropometry data at 24 and 60 months, as well as
information about socioeconomic status, maternal height, gut permeability (lactulose-mannitol z-score (LMZ)),
dietary intake from 9 to 24 months, and micronutrient status. Anthropometric changes were in height- or weight-
for-age z-score (HAZ, WAZ), their absolute difference from the growth standard median (HAD (cm), WAD (kg)), as
well as recovery from stunting/underweight. Outcomes were modeled using multivariate regression.
Results: At 24 months, almost half of the cohort was stunted (45%) and 21% were underweight. Among those who
were stunted at 24 months (n = 426), 185 (43%) were no longer stunted at 60 months. Most children increased their
HAZ from 24 to 60 months (81%), whereas fewer (33%) had positive changes in their HAD. Linear regression models
indicate that girls improved less than boys from 24 to 60 months (HAZ: -0.21 (95% CI -0.27, -0.15); HAD: -0.75 (-1.07,
-0.43)). Greater intestinal permeability (higher LMZ) at 0–24 months was associated with lower relative and absolute
changes from 24 to 60 months (HAZ: -0.10 (-0.16, -0.04); HAD: -0.47 (-0.73, -0.21)). Maternal height (per 10 cm) was
positively associated with changes (HAZ: 0.09 (0.03, 0.15); HAD: 0.45 (0.15, 0.75)). Similar relationships were identified
for changes in WAZ and WAD.
Conclusions: The study children demonstrated improved growth from 24 to 60 months of age, but only a subset
had positive changes in HAD and WAD. The same environmental factors were associated with growth from 24 to
60 months regardless of metric used (change in HAZ or HAD, or WAZ and WAD).
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Background
Poor growth in early childhood is associated with in-
creased risk of morbidity and mortality [1–4], as well as
with longer-term negative effects on cognitive develop-
ment and economic productivity [5–7]. Scientific evi-
dence over decades of research suggested that in early
childhood, growth faltering can be reversed and catch-
up growth can occur through improved nutrition and
other inputs (e.g., reduced disease frequency), but after
2–3 years of age, such inputs are less likely to result in
catch-up growth [8, 9]. This research emphasized the
need for prevention and control of linear growth falter-
ing and stunting in the first 2 years of life, and this has
led to a focus on “the first 1000 days”, recognizing as
well the importance of the maternal nutrition environ-
ment for child growth and development [10].
The literature documenting the reduced likelihood of
catch-up growth after 2–3 years of age led many to con-
sider that children who were stunted at age 2 years
would never exhibit catch-up growth and remain
stunted at later ages. There are now numerous studies
published in which children with height-for-age z-scores
(HAZ) < - 2 (i.e., stunted) in early childhood were found
to have HAZ > - 2 later in childhood or adolescence
[11–15], suggesting that the growth of some children
does improve after the age of 2 years. For example, a girl
who is approximately 4.5 cm shorter than the median
length at 6 months old is the equivalent of - 2 HAZ
(2.3rd percentile), but the same absolute difference in
cm at 24 months old would equate to being - 1.4 HAZ
(8th percentile), hence the appearance of a relative re-
covery toward the median. Leroy et al. [16] made the ob-
servation that because normal child growth is
heteroscedastic (i.e., the variability of size (height or
weight) increases with age), the absolute difference be-
tween the median and standard deviation quantiles in-
creases with age. This means that children may continue
to grow poorly but their status will fall more within the
limits of the distribution. Leroy et al. [16] pointed out
that in terms of the absolute difference in height-for-age
from the median (HAD, in cm), improvements in HAZ
over time do not necessarily represent a recovery of cen-
timeters foregone.
This contradiction between apparent gains in HAZ
concomitant with greater absolute HAD challenges our
understanding of the impact of programs or other influ-
ences on child growth during the pre-school period.
Since the publication by Leroy et al. [16], researchers
have compared differences in HAZ and HAD by age to
evaluate this phenomenon [17, 18]. Here, we use longi-
tudinal data from the Etiology, Risk Factors, and Interac-
tions of Enteric Infections and Malnutrition and the
Consequences for Child Health and Development Pro-
ject (MAL-ED) to evaluate child growth in terms of
height and weight (HAZ, HAD, weight-for-age z-score
(WAZ), and weight-for-age difference (WAD)) from 24
to 60 months, and to evaluate factors associated with
positive changes in relative versus absolute metrics. We
ask the following questions: 1) Is there a difference in
the assessment of growth from 24 to 60months when
considered in relative versus absolute terms?, and 2) are
there differences in the early life factors associated with
growth from 24 to 60 months, depending on which
metric is used?
Methods
The overall goal of the MAL-ED longitudinal multi-site
birth cohort study was to evaluate the relationships be-
tween the child’s environment and experience (dietary,
illness, and pathogen exposure, among others) and
growth and cognitive development from birth to 24
months [19]. It was conducted in eight sites; however,
two sites were excluded from this analysis, one because
of anthropometric data collection irregularities (Naush-
ero Feroze, Pakistan (PKN)) and one because the
cohort's prevalence of children with HAZ < - 2 is consist-
ent with the WHO standards (Fortaleza, Brazil (BRF)).
The six sites that remained in the analysis were: Dhaka,
Bangladesh (BGD); Vellore, India (INV); Bhaktapur,
Nepal (NEB); Loreto, Peru (PEL); Venda, South Africa
(SAV), and Haydom, Tanzania (TZH). Each site enrolled
at least 200 children within 17 days after birth who were
born singleton to a mother who was at least 16 years of
age, and who weighed at least 1500 g at birth and con-
sidered generally healthy. Enrollment began in Novem-
ber 2009, with follow up through February 2014, and
through additional funding, a follow-up of these children
at 60 months was completed in February 2017 [20]. The
protocols were reviewed by appropriate Institutional Re-
view Boards (IRB) in each site and written consent was
obtained from the family, both for the initial protocol,
and for the follow-up. More detailed descriptions of the
study protocol have been published [21–24]; here we
provide details most relevant for these analyses.
Anthropometry
Trained field workers visited the households monthly to
measure child length and weight during the first 24
months of life and at least quarterly thereafter until 60
months [20], although due to funding and IRB approval
gaps, this was inconsistently practiced at the sites. The
length (≤ 24months) or height (> 24months), hereafter
referred to as height, and weight measures were then
converted to sex- and age-specific HAZ and WAZ using
the WHO 2006 growth standards [25]. Absolute HAD
and WAD were calculated by subtracting the WHO ref-
erence median height or weight for a child of the same
age and sex from the measured value. Changes in HAZ,
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HAD, WAZ and WAD were calculated by subtracting
the 24-month value from the 60-month value. Field
workers additionally measured maternal height 2 months
after the child was enrolled in the study. For analyses,
children were required to have height and weight values
at 0, 24, and 60months of age, allowing for a ± 30-day
window. Stunting is defined as HAZ < -2 and under-
weight is defined as WAZ < -2.
Socioeconomic status
Household socioeconomic information was collected
every 6 months. In order to have a common measure of
socioeconomic status across the sites, an indicator was
developed combining information on household Water
and sanitation status, Assets, Maternal education, and
Income (WAMI) [26]. The WAMI index ranges from 0
to 1, with a higher value indicating a higher socioeco-
nomic status for the household. We calculated the mean
WAMI score when the child was 30 and 36 months old
in order to best represent their socioeconomic status be-
tween 24 and 60 months.
Illness surveillance
Trained fieldworkers visited the homes bi-weekly during
the first 24 months of life to query caregivers about signs
and symptoms of morbidity for common illnesses [21].
From this, the prevalence and incidence of diarrhea and
respiratory illnesses were calculated. Stool samples were
taken during each diarrheal episode and tested to deter-
mine etiology [27]. Monthly surveillance stools were also
collected and subjected to testing to evaluate pathogen
carriage.
Gut function
The lactulose:mannitol (L:M) test [23] was performed at 3,
6, 9, and 15months to assess the permeability and absorp-
tive capacity of the gut during the first 24months of life.
We generated age and sex standardized z-scores for the L:
M ratios [28] (LMZ) and calculated the mean value of
these over the first 24months of life for each child. A
greater value indicates greater enteric dysfunction, using
the BRF site as the reference. From each of the monthly
(non-diarrheal) surveillance stools, three indicators of gut
inflammation and permeability were also assessed: neop-
terin, myeloperoxidase, and alpha-1-antitrypsin [23].
Diet
From enrollment to 24months, during the bi-weekly
morbidity surveillance, caregivers were queried about
breastfeeding and the feeding of other liquids and solids.
From 9 to 24 months, trained field workers utilized a
quantitative 24-h recall questionnaire to quantify intakes
of non-breast milk foods on a monthly basis [22]. The
food intakes were transformed into energy, macro-, and
micro-nutrients using study-created food composition
databases. Due to co-linearity observed in the dietary
data components, only energy intake and the protein
density of the diet were included in our analysis. Using
the residual method [29], we performed a regression of
mean protein intake on mean energy intake and consid-
ered the residuals as an indicator of usual protein dens-
ity. A similar process was used for the intakes of
micronutrients included in the supplementary materials
in order to derive other measures of the nutrient density
in the diet.
Micronutrient status
Blood samples were taken by venipuncture at 7, 15, and
24months of age to characterize iron, zinc, and vitamin
A status of the child. Plasma concentrations of retinol
and zinc were used to characterize vitamin A and zinc
status, respectively. Plasma ferritin and plasma transfer-
rin receptor (TfR) were assessed as indicators of iron
status. At each time point, and at 60 months,
hemoglobin concentration was obtained using the
HemoCue method to detect anemia. Biochemical con-
centrations were adjusted for inflammation using plasma
alpha-1-acid glycoprotein (AGP) [30], and transformed
using a square root function.
Statistical methods
The distributions of HAZ, HAD, WAZ, and WAD
were plotted at 0, 24, and 60 months of age. The rela-
tionship between changes in HAZ and HAD (and
WAZ and WAD) between 24 and 60 months were
plotted and quantified with correlation coefficients (r).
Children were identified as stunted or underweight at
24 and 60 months and these categories were used to
identify the persistence of or recovery from stunting
and underweight status. We used linear regression,
controlling for study site, to evaluate factors associ-
ated with changes in in HAZ, HAD, WAZ, and
WAD. Based on previous analyses of factors related
to growth [20, 31, 32], socioeconomic status (WAMI),
child’s sex, study site, maternal height, and the value
of HAZ, HAD, WAZ or WAD at 24 months were in-
cluded in each base model. We used biologic ration-
ale, data completeness, and stepwise selection
(forward and backward improvements to the Akaike
Information Criterion (AIC)) to identify other vari-
ables for inclusion, which were tested in a model that
included all variables in the base model, plus the vari-
able under consideration. A list of the variables that
were considered can be found in the supplemental
materials (Supplemental Table 1). Models were run in
R 3.4.3 (Foundation for Statistical Computing, Vienna,
Austria).
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Results
Among the 1635 children enrolled in the six MAL-ED
sites included in these analyses, 1040 (64%) had anthro-
pometry at 0, 24, and 60months of age, and the sample
size decreased to 942 (58%) when we required that the
children have at least one observation for each of key
variables found to be associated with growth outcomes
at 60 months in a previous publication using data from
this cohort [20]: transferrin receptor, LMZ, maternal
height, WAMI, and dietary intake 9–24 months (Fig. 1).
We compared the baseline HAZ, WAZ, and WAMI
scores between those who were included in the analysis
and those who were not and found no statistically sig-
nificant differences for LAZ at enrollment and mean
WAMI scores, but the WAZ at enrollment were statisti-
cally significantly lower for those included in this ana-
lysis than in those who were not (Supplemental
Table 2).
HAZ values were highest at enrollment, lowest at 24
months, and intermediate at 60 months (Fig. 2 and
Table 1). WAZ values were also highest at enrollment,
but the values at 24 and 60months were overlapping.
HAD and WAD values were smallest (closer to median)
at enrollment and became larger at 24 and at 60 months.
Just under half of the children included in this analysis
were stunted at 24 months (Table 2), and approximately
one-fifth of the children were underweight at 24 months.
Children who were not stunted or underweight at 24
months were unlikely to be stunted or be underweight
at 60 months (Table 3). Category switches from stunted
to non-stunted (and underweight to non-underweight)
were common between 24 and 60months.
Shown in Fig. 3 are the patterns of mean HAZ and
HAD amongst those who were never stunted, those who
remained stunted and those who recovered from stunt-
ing. A figure capturing these same relationships for
WAZ and WAD is also shown. Among those who were
stunted or underweight throughout, the mean HAD or
WAD continued to decrease until nearly 60 months, but
flattened out at around 24months of age for those who
were no longer stunted or underweight at 60 months.
Changes in HAZ and HAD between 24 and 60months
were highly correlated (r = 0.80), as were changes in
WAZ and WAD (r = 0.77) (Fig. 4).
Fig. 1 Flow chart of participants included in the analysis from the MAL-ED study
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Most children had a positive change in their HAZ
from 24 to 60months, whereas far fewer had a positive
change (smaller difference from median) in their HAD
(Table 2). In general, positive changes in WAZ and
WAD were less common than for HAZ and HAD.
Results of multivariable linear regression models ad-
justed for HAZ or HAD at 24months indicate that
child’s sex, maternal height, and mean LMZ were both
associated with change in HAZ, HAD, WAZ and WAD
from 24 to 60months (Table 3). Greater average LMZ, a
marker of intestinal permeability, was negatively associ-
ated with changes in both HAZ and HAD from 24 to 60
months. Results were similar, although not always statis-
tically significant for the Poisson regression models con-
sidering positive changes in HAZ or HAD as the
outcome variable (Supplemental Table 3). Higher mean
TfR in the first 24 months of life was associated posi-
tively with changes in WAZ and WAD, whereas the
average protein density from complementary foods was
negatively associated with changes in WAZ and WAD
from 24 to 60months. WAMI (a measure of socioeco-
nomic status) was positively associated with changes in
WAZ and WAD, but when the binary outcomes were
considered (positive change in WAZ or WAD, recovery
from underweight), the associations with WAMI were
not statistically significant (Supplemental Table 3).
Discussion
Populations with a high prevalence of stunting tend to
have height distributions that are negatively shifted, ra-
ther than skewed, compared with the standard WHO
distribution. This suggests that the entire population, ra-
ther than a subset, is not growing to their potential [33].
In these data, from 24 to 60 months of age, the distribu-
tion of HAZ shifted to the right, indicating a positive
change in height relative to their position at 24 months.
However, as has been demonstrated in other studies [16,
18], the HAD distribution shifted further to the left from
24 to 60 months of age, indicating that children had
greater absolute height deficits at 60 months than they
had at 24 months when compared with the WHO me-
dian. For weight, the distributions of WAZ at 24 and 60
months were very similar, whereas the WAD distribu-
tion shifted more to the left from 24 to 60months, indi-
cating greater weight deficits at 60 months.
As discussed earlier, the apparent contradiction be-
tween relative and absolute height and weight deficits
stems from the increasing variance of normal child
growth which is depicted in the WHO z-score calcula-
tions. Leroy et al. [16] have suggested that HAD is a
more meaningful way to measure catch-up growth in a
population, whereas Victora et al. [34] argued that
changes in HAZ and HAD are both meaningful ways to
Fig. 2 Probability distributions of height-for-age z-scores (HAZ), weight-for-age z-scores (WAZ), and weight-for-height z-scores (WHZ) at 0, 24, and
60months in the MAL-ED cohort study sites
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express changes in linear growth in children, and that
they give complementary information. Here we have
shown that in low-income settings, children who show
positive changes in HAD are a subset of those who show
positive changes in HAZ and are more likely to be those
with greater positive changes in HAZ. This is also true
for WAZ and WAD, except that positive changes in
WAD are much less likely to be observed. Because of
the overall high correlation between the changes in the
indicators from 24 to 60months (as shown in Fig. 4), it
is not surprising that we did not identify factors in early
life that distinguish between these two types of changes
over time. Given the similarity of the factors associated
with change in HAZ and HAD from 24 to 60months
(child sex, maternal height, and LMZ), both metrics are
informative when evaluating environmental influences
on the growth of children.
Maternal height was associated positively with change
in each of the four metrics from 24 to 60months. For
linear growth (change in HAZ), the association is smaller
in effect size but consistent with findings by Addo et al.
[35] of positive associations between maternal height
and linear growth from 24months to mid-childhood in
five low- and middle-income countries. Here we extend
that finding by showing positive associations with
change in HAD. As discussed by Addo et al. [35], the
persistence of associations between maternal height and
linear and somatic growth likely reflect genetic and non-
genetic factors as well as intergenerational factors.
Greater average LMZ was associated with negative
changes in each of the four outcomes from 24 to 60
months. Greater LMZ is generally regarded as a measure
of environmental enteric dysfunction (EED). Previously,
we have demonstrated small negative associations with
linear growth velocity in the first 24 months of life [36],
but statistically significant negative associations with
both attained HAZ and WAZ at 60months [20]. The re-
sults here are consistent with this latter finding.
Whether EED in early childhood has long-term negative
consequences for child growth throughout the pre-
school period or whether average LMZ during the first
24 months is a marker for EED from 24 to 60months is
not known.
This hypothesis may also explain findings related to
TfR. Previously we have shown positive associations be-
tween mean TfR in early childhood and attained WAZ
and HAZ at 60 months [20]. Here, the direction of the
results is consistent, but the associations are statistically
significant for WAZ and WAD only. It is known that
TfR is elevated with iron-deficient erythropoiesis and
with inflammation (which we adjusted for using AGP),
but it is also known to be elevated with cellular prolifer-
ation, including erythropoiesis during periods of growth.
Thus, associations of TfR in early childhood with growth
may reflect greater cellular proliferation, the underlying
cause of which is not known. Why variability would be
uniquely associated positively with changes in WAZ and
WAD from 24 to 60months requires further research.
That the protein density of complementary foods was
negatively associated with changes in WAZ and WAD
from 24 to 60months is somewhat surprising because
the same measure was found to be positively associated
with growth in weight and length through 24months
[32]. Findings from prior studies (reviewed by Michael-
sen and Greer [37]) suggest that higher protein intakes
before age 2 years are associated with greater BMI at 4
years of age and older. These findings may not be
Table 1 Characteristics of children with anthropometry at 0, 24,
and 60 months of age in the MAL-ED study, including height-
for-age z-score (HAZ), height-for-age difference (HAD), weight-
for-age z-score (WAZ), and weight-for-age difference (WAD).
Stunting is defined as HAZ < -2, underweight is defined as
WAZ < -2
N 942
No. girls (%) 474 (50.3)
Mean SES scorea (SD) 0.6 (0.2)
Mean Lactulose:Mannitol z-scoreb (SD) 0.4 (0.6)
Maternal height, cm (SD) 152.2 (6.5)
Mean energy intakec, kcal/d (SD) 838.0 (360.8)
Mean protein intakec, g/d (SD) 23.3 (10.5)
Mean transferrin receptord, mg/L (SD) 6.0 (3.1)
# stunted at 0 mo (%) 130 (13.8)
# stunted at 24 mo (%) 426 (45.2)
# stunted at 60 mo (%) 256 (27.2)
Mean HAZ at 0 mo (SD) -0.9 (1.0)
Mean HAZ at 24 mo (SD) -1.9 (1.0)
Mean HAZ at 60 mo (SD) -1.4 (0.9)
Change HAZ 24 to 60 mo (SD) 0.5 (0.6)
Change HAD 24 to 60 mo (cm) -1.0 (2.5)
# underweight at 0 mo (%) 130 (13.8)
# underweight at 24 mo (%) 202 (21.4)
# underweight at 60 mo (%) 184 (19.5)
Mean WAZ at 0 mo (SD) -0.8 (1.1)
Mean WAZ at 24 mo (SD) -1.2 (1.0)
Mean WAZ at 60 mo (SD) -1.2 (1.0)
Change WAZ 24 to 60 mo (SD) 0.0 (0.7)
Change WAD 24 to 60 mo (kg) -1.1 (1.6)
aSocioeconomic score is the mean of values at 30 and 36months. The score
was generated for the MAL-ED study and based on Water and sanitation,
Assets, Maternal education, and Income (WAMI) [26]
bLactulose:Mannitol tests were conducted 3, 6, 9 and 15 months and
transformed into z-scores, and the mean of 1–4 z-scores was calculated
per child
cRepresents the mean intake per child of non-breast milk foods assessed
monthly from 9 to 24 months (range 11–17 assessments per child)
dMean of 1–3 measures per child assessed at 7, 15, and 24 months
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generalizable to our study children for several reasons.
The majority of children in MAL-ED were breastfed
through 18+ months of life. Animal milks contributed to
the overall protein density of their diet during the first
24 months, but the protein intakes (% energy) were on
the order of 10–12%, and the frequency of animal milk
consumption declined > 24 months.
One of the primary strengths of this study is the longi-
tudinal data that allow for detailed analysis of growth in
early childhood across six sites with high rates of stunt-
ing. The extensive data on risk factors collected during
the study allow for evaluation of risk factors for growth
across different categories, measured in a common way
across the sites. However, there are also some limitations
to this analysis. Iron deficiency may be underestimated
because we adjusted for inflammation using only one
marker. There are community-level factors that likely
affect the growth of all children at a site, as well as other
unmeasured risk factors, and those contribute to the un-
explained variance of our models. In addition, the gaps
in funding and IRB approvals for the follow up study led
to inconsistencies in data collection across sites depend-
ing on whether sites could maintain field activities dur-
ing the gap period and resulted in many children with
missing data in some sites. Thus, our analyses necessar-
ily focus on factors assessed during the first 24 months
of life, and it may be that longitudinal data sets with
more extensive data from 24 to 60months may be able
to identify specific factors during that period associated
with positive changes in HAD amongst those with posi-
tive changes in HAZ over time. There was considerable
loss to follow-up between 2 and 5 years, and this limited
our sample size. When we compared some key charac-
teristics, those who were lost to follow up or excluded
Table 2 Summary of transitions between stunted and non-stunted status, and underweight and non-underweight status at 24 and
60months in the cohort. Number (%) of children with positive changes in growth (linear and ponderal), defined as positive change
in height-for-age z-score (HAZ), weight-for-age z-score (WAZ), height-for-age difference (HAD), or weight-for-age difference (WAD),
and recovery from stunting (HAZ < -2) or underweight (WAZ < -2). Changes were calculated by subtracting the value at 24 months
from the value at 60 months of age. Stunting is defined as height-for-age z-score (HAZ) < - 2, underweight is defined as weight-for-
age z-score (WAZ) < - 2
Height N (%) Weight N (%)
Not stunted at 24 or 60 months 501 (53) Not underweight at 24 or 60months 689 (73)
Not stunted at 24, stunted at 60months 15 (2) Not underweight at 24, underweight at 60 months 51 (5)
Stunted at 24, not at 60 months 185 (20) Underweight at 24, not at 60 months 69 (7)
Stunted at both 24 and 60 months 241 (26) Underweight at both 24 and 60 months 133 (14)
Positive change in HAZ 763 (81) Positive change in WAZ 469 (50)
Positive change in HAD 308 (33) Positive change in WAD 166 (18)
Recovery from stunting 185/426 (43) Recovery from underweight 69/202 (34)
Table 3 Results from linear regression models with the outcomes of height-for-age z-score (HAZ), height-for-age difference (HAD),
weight-for-age z-score (WAZ), and weight-for-age difference (WAD) change between 24 and 60months as a function of
anthropometry at 24 months and other child and household factors in six sites from the MAL-ED study (BGD, INV, NEB, PEL, SAV,
TZH)
Δ 24 to 60mo (n = 942)
ΔHAZ (SE) ΔHAD (SE) ΔWAZ (SE) ΔWAD (SE)
HAZ at 24 mo - 0.25 (0.02)***
HAD at 24 mo 0.12 (0.03)***
WAZ at 24 mo -0.26 (0.02)***
WAD at 24 mo 0.33 (0.04)***
SES score, 30–36 mo (10% increase) 0.01 (0.01) 0.03 (0.06) 0.04 (0.02)* 0.09 (0.04)*
Boys 0, Girls 1 -0.21 (0.03)*** -0.75 (0.16)*** - 0.16 (0.04)*** -0.48 (0.09)***
Maternal height (per 10 cm) 0.09 (0.03)** 0.45 (0.15)** 0.10 (0.04)* 0.22 (0.09)*
Mean Lactulose:Mannitol z-score -0.10 (0.03)*** -0.47 (0.13)*** - 0.13 (0.03)*** -0.28 (0.08)***
Mean energy intake 9–24 mo 0.01 (0.02) 0.07 (0.08) -0.02 (0.02) -0.02 (0.05)
Protein density 9–24 mo -0.01 (0.02) - 0.03 (0.08) -0.05 (0.02)* - 0.11 (0.05)*
Mean transferrin receptor, inflammation adjusted [30] 0.00 (0.01) 0.01 (0.03) 0.02 (0.01)* 0.04 (0.02)*
***p < 0.001, **p < 0.01, *p < 0.05
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due to missing variables were similar with respect to mean
LAZ at enrollment and socioeconomic status, but had sta-
tistically significantly higher WAZ at enrollment than did
those who were retained. We expect that the WAZ differ-
ence is primarily due to differential follow up at sites (the
South African and Peruvian sites had higher WAZ at en-
rollment than the other sites and higher loss to follow up);
because we are controlling for site in the analysis, we ex-
pect that to have little effect on our results.
Conclusions
In six MAL-ED sites, almost half (43%) of the children
who were stunted at 24 months of age were no longer
stunted at 60 months of age, indicating some degree of
Fig. 3 Average z-score (left y-axis, dashed line) and height/weight-for-age difference (right y-axis, solid line) by month of age, among children
who were stunted / underweight at 24 and 60 months (red), > - 2 at 24 months and < -2 at 60 months (orange), stunted / underweight at 24
months and not stunted / underweight at 60 months (blue), and not stunted / underweight at either 24 or 60months (green)
Fig. 4 Difference in height/weight-for-age z-scores and height/weight-for-age centimeters/kilograms between 24 and 60months of age at six
MAL-ED sites
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improvement in linear growth from 24 to 60 months.
Very few children developed stunting after 24 months of
age. Most of the children demonstrated some improve-
ment in HAZ, and except for SAV, only about 30% had
improvement in HAD. Fewer children had a positive
change in WAZ, and most of the children with a positive
WAD were in the sites in Peru and South Africa. Given
the high correlation and the similarity in factors associ-
ated with changes in z-scores or absolute difference, we
conclude that both approaches can be used to under-
stand factors associated with child growth from 24 to 60
months.
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